Venture Investment Bank for Early Stage Technology Companies

1
(No Transcript)
2
Who We Are

• Venture Investment Bank for Early Stage
  Technology Companies
• We Invest Through
• Angel Institutional Investor Members
• Capital Managed Internally
• NASD\Broker Dealer

3
The Fact is

• VCs Dont Invest in Early Stage Companies
• Angels Do!

4
Early Stage

• Seed A Round B Rounds Mezzanine
  IPO/Exit

Capital Chasm
200k .5 5M 10M
10 - 30M 40M

5
Ten Highly Effective Habits of Successful Angel
Investing

• 1. Get out 20 Envelopes

6
Ten Highly Effective Habits of Successful Angel
Investing

• 2. Be Quick but dont Hurry

7
Ten Highly Effective Habits of Successful Angel
Investing

• 3. Invest in Deals you Understand

8
Ten Highly Effective Habits of Successful Angel
Investing

• 4. Dont try to change the Company

9
Ten Highly Effective Habits of Successful Angel
Investing

• 5. Do your own Competitive Analysis Research

10
Ten Highly Effective Habits of Successful Angel
Investing

• 6. Get to KNOW the Customer

11
Ten Highly Effective Habits of Successful Angel
Investing

• 7. Really get to KNOW the Team

12
Ten Highly Effective Habits of Successful Angel
Investing

• 8. Never, ever Fall in Love

13
Ten Highly Effective Habits of Successful Angel
Investing

• 9. Know the Intellectual Property

14
Ten Highly Effective Habits of Successful Angel
Investing

• 10. Know who you pass the Baton to before you
  invest

15

• Our Value Proposition
• is

Superior Deal Selection Superior Deal Support
16
Deal Selection Process

• Initial Screening by Angel Capital Staff
• Qualified Deals go to Expert Angel
• Members for Analysis
• Engage VCs in Due Diligence Review
• Engage Relevant Strategic Investors

17
Deal Selection Criteria

• Angel Investors with Deep Relevant Industry
  Experience Willing to
• Invest
• Serve as Advisors
• VCs Willing to Fund Later Rounds Based on Certain
  Milestones
• Defensible IP

18
Deal Support

• Introduce
• Expert Angels Who Invest and Join Board
• Industry Board Members
• Strategic Relationships
• VCs with Relevant Expertise
• Valuation and Deal Structure
• Ongoing Corporate Finance Services

19

• Disruptive Technology in Intelligent Storage
  Networks
• 12 patents filed, more to come
• Market projected to grow 900 by 2003 to 6.7B
• Experienced management team has built two
  successful companies
• Elite industry board
• Key industry relationships in place

20
BioRight International, Inc.

• Breakthrough Nonprescription Cold
• Allergy Medicines
• Launched 11/00 - Sales Exceeding 1.3 Million
• Distribution in Over 22,000 Retail Pharmacies
  Walgreens, Rite-Aid, Eckerds, Safeway, Osco,
  Longs
• Pipeline for New Product Introductions
• Revenue Growth to Over 100 Million Within 5
  Years
• Management Combines Medical Expertise With 25
  Year Track Record of Retail Product Introductions

21

• Multifocal Contact Lens With Strong Patents and
  High Consumer Demand
• Clinical Data Consistently Outperforms Any Lens
  on the Market (Including JJ Acuvue)
• FDA Approval Received for
• Custom (Lathed Lens) Launched in US and Canada
• Cast Molded Lens (Disposable Mass Produced)
• CE Mark Received for Astigmatic Intraocular Lens

22
Contact Information

• Mike Pogue - President
• [phone]
• mpogue_at_angelcapitalnetwork.com

23
(No Transcript)